M34101-040: An International, Non-comparative, Open-Label Study Of PS-341 Administered to Patients with Multiple Myeloma Who Experienced Relasped Or Progressive Disease After Recieving at Least Four Previous Treatment Regimens...

Short title	M34101-040: An International, Non-comparative, Open-Label Study Of PS-341 Administered to Patients with Multiple Myeloma Who Experienced Relasped Or Progressive Disease After Recieving at Least Four Previous Treatment Regimens...
Status	Finished
Effective start/end date	3/02/03 → 31/03/06

Project Details